目的研究神经激肽3受体(NK 3r)在胰腺癌组织中的表达，并将结果结合临床资料分析，以期找出其中相关性。
Objective to investigate the expression of neurokinin-3 receptor (NK-3R) in pancreatic cancer and evaluate the relationship between expression of this receptor and clinical aspect.
本发明涉及某些喹啉化合物，其用作神经激肽- 1 (NK - 1)受体拮抗剂，和速激肽及特别是P物质抑制剂。
The present invention is directed to certain quinoline compounds which are useful as neurokinin-1 (NK-1) receptor antagonists, and inhibitors of tachykinin and in particular substance p.
本发明涉及某些内酰胺化合物，其适用作神经激肽- 1 (NK - 1)受体拮抗剂，速激肽特别是P物质抑制剂。
The present invention is directed to certain lactam compounds which are useful as neurokinin-1 (NK-1) receptor antagonists, and inhibitors of tachykinin and in particular substance p.
本发明涉及某些内酰胺化合物，其适用作神经激肽- 1 (NK - 1)受体拮抗剂，速激肽特别是P物质抑制剂。
The present invention is directed to certain lactam compounds which are useful as neurokinin-1 (NK-1) receptor antagonists, and inhibitors of tachykinin and in particular substance p.
应用推荐